UNSPSC 51382002: Lufuradom

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C22H20FN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GS8D070P7W, chemically known as (- )-n-((8-fluoro-2,3-dihydro-1-methyl-5-phenyl-1h-1,4-benzodiazepin-2-yl)-methyl)-3-furamide. but generally known as lufuradom, which bears US NIH Compound Identifier 3045400. European Medicines Agency schedules Lufuradom in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08617MIG.

UNSPSC 51382002 Lufuradom, a Commodity code, covers naloxone and drug deactivation systems that state and local health agencies procure to support community health and harm-reduction initiatives. The work involves supplying pharmaceutical countermeasures and related safety equipment on recurring annual contracts with quarterly delivery schedules to designated public facilities. Issuing bodies under this code include county health departments and similar public health authorities managing overdose-response and substance-abuse programs.

Seminole County, Florida represents the recent activity on this code, having released an IFB in mid-2026 (IFB60459723LAS, posted June 30, 2026) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with a one-year renewal option and includes standard compliance requirements such as E-Verify, drug-free workplace certification, and workers' compensation and commercial general liability insurance. Bidders must include all shipping and delivery costs in their pricing and meet potential FEMA funding compliance obligations if the contract is federally funded.